ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

ESMO 2024 Insights: OS Results for Pembro + CRT for High-Risk Locall…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

Cancer Screening Molecular Tools

Fengting Yan

Induction CT Followed by Standard CRT vs. CRT Alone in Locally Advan…

Gemma Eminowicz

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

Durvalumab/C/T as 1L Treatment for dMMR Advanced Endometrial Cancer:…

Dana Chase